相关实验视频
Updated: May 12, 2025

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.6K
针对NRAS突变黑色素瘤的MAPK途径:从机制到临床
Yi Wang1, Guangchao Xu2,3, Hongwei Xia4
1Department of Medical Aesthetics, Affiliated Hospital of Southwest Jiaotong University, The Third People's Hospital of Chengdu, Chengdu, Sichuan, China.
The British journal of dermatology
|May 9, 2025
概括
针对突变NRAS黑色素瘤,一个预后不佳的癌症,正在推进. 新疗法侧重于NRAS-MAPK通路,包括MEK抑制剂和组合治疗,提供更好的结果.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
背景情况:
- 突变NRAS是黑色素瘤的常见驱动因素,与患者预后不佳有关.
- 目前针对NRAS突变黑色素瘤的向治疗策略仍然有限.
- NRAS-MAPK信号通路在黑色素瘤致癌过程中至关重要.
研究的目的:
- 系统地审查针对黑色素瘤突变NRAS及其下游效应因子 (RAF,MEK) 的最新进展.
- 探索针对MAPK途径的组合疗法,以及其他方式,如免疫疗法.
- 讨论NRAS突变黑色素瘤向治疗中的当前挑战和未来战略.
主要方法:
- 关于最近临床进展和治疗策略的文献综述.
- 直接NRAS准和下游途径抑制的系统概述.
- 分析包括免疫疗法在内的组合疗法.
主要成果:
- 在准NRAS-MAPK通路方面取得了显著的临床进展.
- 像MEK抑制剂 (例如,tunlametinib) 和组合疗法 (例如,naporafenib/trametinib) 这样的新疗法显示出有前途.
- 涉及免疫治疗的组合策略正在出现.
结论:
- 准NRAS-MAPK通路为NRAS突变黑色素瘤提供了一个有希望的治疗途径.
- 解决当前的问题和探索新的对策对于优化治疗结果至关重要.
- 对组合疗法的进一步研究有可能改善NRAS突变黑色素瘤患者的生存率.
相关概念视频
MAPK Signaling Cascades
4.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
4.9K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
The Ras Gene
6.1K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.1K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
Small GTPases - Ras and Rho
3.8K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.8K
Mitogens and the Cell Cycle
6.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K

